Properties of FDA-approved small molecule protein kinase inhibitors

R Roskoski Jr - Pharmacological research, 2019 - Elsevier
Because mutations, overexpression, and dysregulation of protein kinases play essential
roles in the pathogenesis of many illnesses, this enzyme family has become one of the most …

Chemotherapy in pancreatic cancer: a systematic review

L Hajatdoost, K Sedaghat, EJ Walker, J Thomas… - Medicina, 2018 - mdpi.com
Background and Aim: Pancreatic cancer is one of the most fatal cancers. Cytotoxic
chemotherapy remains the mainstream treatment for unresectable pancreatic cancer. This …

Landscape of combination therapy trials in breast cancer brain metastasis

J Fares, D Kanojia, A Rashidi, I Ulasov… - … journal of cancer, 2020 - Wiley Online Library
Combination therapy has become a cornerstone in cancer treatment to potentiate
therapeutic effectiveness and overcome drug resistance and metastasis. In this work, we …

Development of lapatinib nanosponges for enhancing bioavailability

PP Prabhu, TV Gujaran, CH Mehta, A Suresh… - Journal of Drug Delivery …, 2021 - Elsevier
The present study is aimed to formulate lapatinib nanosponges (LPT NSs) to enhance its
aqueous solubility and bioavailability. LPT loaded NSs were fabricated using Eudragit …

Advances in the diagnosis and treatment of leptomeningeal disease

A Sharma, JT Low, P Kumthekar - Current neurology and neuroscience …, 2022 - Springer
Abstract Purpose of Review Leptomeningeal disease (LMD) is a rare, late complication of
systemic cancer and is associated with significant neurological morbidity and high mortality …

[HTML][HTML] In vitro anti-proliferative effect of capecitabine (Xeloda) combined with mocetinostat (MGCD0103) in 4T1 breast cancer cell line by immunoblotting

HK Çakir, O Eroglu - Iranian journal of basic medical sciences, 2021 - ncbi.nlm.nih.gov
Objective (s): Mouse breast cancer cell line 4T1 can accurately mimic the response to
immune receptors and targeting therapeutic agents. Combined therapy has emerged as an …

Cardiotoxicity from capecitabine chemotherapy: prospective study of incidence at rest and during physical exercise

C Lestuzzi, D Stolfo, A De Paoli, A Banzato… - The …, 2022 - academic.oup.com
Background Physical activity may increase the risk of cardiotoxicity (myocardial ischemia,
major arrhythmias) of 5-Fluorouracil, but this risk has never been investigated for its prodrug …

Paraoxonase-1 activity in breast cancer patients treated with doxorubicin with or without trastuzumab

EW Thompson, BG Demissei, AM Smith… - Basic to Translational …, 2022 - jacc.org
The objective of this study was to determine associations of paraoxonase-1 (PON-1) with
development of cancer therapy–related cardiac dysfunction (CTRCD). PON-1 is a …

Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer …

B Abrahams, A Gerber, DC Hiss - International Journal of Molecular …, 2024 - mdpi.com
The role of the epidermal growth factor receptor (EGFR) in tumor progression and survival is
often underplayed. Its expression and/or dysregulation is associated with disease …

Monitoring activities of receptor tyrosine kinases using a universal adapter in genetically encoded split TEV assays

JP Wintgens, SP Wichert, L Popovic… - Cellular and molecular …, 2019 - Springer
Receptor tyrosine kinases (RTKs) play key roles in various aspects of cell biology, including
cell-to-cell communication, proliferation and differentiation, survival, and tissue homeostasis …